Delos Capital
15
9M
5
1.67
4
0.07
- Stages of investment
- Areas of investment
Summary
Delos Capital is the famous VC, which was founded in 2013. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the New York.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Delos Capital, startups are often financed by ONSET Ventures, New Enterprise Associates, Lumira Ventures. The meaningful sponsors for the fund in investment in the same round are Quadrille Capital, New Enterprise Associates, Lumira Ventures. In the next rounds fund is usually obtained by Square 1 Bank, Questa Capital Management, Quadrille Capital.
We also calculated 8 valuable employees in our database.
Among the most popular portfolio startups of the fund, we may highlight BAROnova, Curamir Therapeutics, OncoMyx Therapeutics. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Medical, Wellness.
The fund is generally included in less than 2 deals every year. The real fund results show that this VC is 42 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Delos Capital works on 16 percentage points less the average amount of lead investments. The important activity for fund was in 2019. The higher amount of exits for fund were in 2016.
Investments analytics
Analytics
- Total investments
- 15
- Lead investments
- 4
- Rounds per year
- 1.67
- Follow on index
- 0.07
- Investments by industry
- Biotechnology (5)
- Health Care (3)
- Therapeutics (3)
- Medical (2)
- Biopharma (2) Show 3 more
- Investments by region
-
- United States (6)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Group Appearance index
- 0.87
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ostial Corporation | 16 Sep 2022 | Health Care, Manufacturing, Medical | Late Stage Venture | 7M | United States, California, Campbell |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.